<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04538339</url>
  </required_header>
  <id_info>
    <org_study_id>CHRO-2020-11</org_study_id>
    <secondary_id>2020-A01333-36</secondary_id>
    <nct_id>NCT04538339</nct_id>
  </id_info>
  <brief_title>Prediction of Arterial Lactate and Blood Gas Values Through the Analysis of Central Venous Blood</brief_title>
  <acronym>PREDIGAZ</acronym>
  <official_title>Prediction of Arterial Lactate and Blood Gas Values Through the Analysis of Central Venous Blood. A Human, Prospective, Multicenter Validation Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Régional d'Orléans</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Régional d'Orléans</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Predicting arterial lactate and blood gas values with sufficient accuracy by simply analyzing&#xD;
      central venous blood would be interesting in intensive care unit patients in whom the&#xD;
      insertion of an arterial catheter or arterial punctures could be avoided. This prospective&#xD;
      study aims at externally validating published mathematical models built to predict arterial&#xD;
      values from central venous blood analysis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mathematical models for predicting arterial blood gas and arterial lactate have recently be&#xD;
      published (PMID 27543529; see the citations section). The aim of the study is to externally&#xD;
      validate these models in a multicenter (11 centres in France) cohort of intensive care unit&#xD;
      patients suffering from acute circulatory failure. For the peru pose of the study, patients&#xD;
      will undergo concomitent central venous/arterial blood sampling from 1 to 4 times during&#xD;
      their intensive cafe unit stay. Clinical characteristics of the patients and central venous&#xD;
      blood gas and lactate values will be used to predicted arterial values according to&#xD;
      previously published formula. Predicted and actual arterial values of each variable of&#xD;
      interest (pH, PaCO2, SaO2, lactate) will then be compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2020</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage error rate when predicting arterial values (pH, PaCO2, SaO2 and lactate) from central venous values.</measure>
    <time_frame>15 minutes</time_frame>
    <description>For each variable of interest (pH, PaCO2, SaO2 and lactate), the percentage of predicted values outside the agreement interval obtained in a previously published study (i.e., -0.078 to +0.084 for arterial pH; -1.32 to +1.36 kPa for PaCO2; -5.15 to +4.47% for SaO2; 1.07 to +1.05 mmol/l for arterial lactate) will be calculated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bias and agreement interval between predicted and actual arterial values for each variable of interest.</measure>
    <time_frame>15 minutes</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Circulatory Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Studied patients will be adult patients admitted to intensive car unit and presenting signs&#xD;
        of acute circulatory failure. Patients should carry arterial and central venous catheters&#xD;
        for their medical needs and not exclusively for the purpose of the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age&gt;18 years&#xD;
&#xD;
          -  patient admitted in a intensive care unit&#xD;
&#xD;
          -  patient already carrying an indwelling arterial catheter and a superior vena cava&#xD;
             central catheter&#xD;
&#xD;
          -  patient presenting an acute circulatory failure defined by the presence of at least&#xD;
             two of the following items: a) Persistent hypotension (systolic arterial blood&#xD;
             pressure &lt; 90 mm Hg or mean arterial pressure &lt; 65 mm Hg) or need for continuous&#xD;
             intravenous vasopressor treatment (at any dose). b) Presence of at least one of the&#xD;
             following signs of hypoperfusionfusion :Change in mental status ; Skin mottling ;&#xD;
             Oliguria (Urine output &lt;0.5 ml/kg body weight for at least one hour); Arterial lactate&#xD;
             &gt; 2 mmol/l or peripheral venous lactate &gt; 3.2 mmol/l; ScvO2 &lt;70%.&#xD;
&#xD;
          -  Routine medical management requires central venous blood sampling for ScvO2&#xD;
             measurement and arterial blood sampling for gazometry.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Opposition to participation in the study&#xD;
&#xD;
          -  Impossibility to take a concomitant arterial and venous gazometric sample.&#xD;
&#xD;
          -  Patient treated with ECMO (extracorporeal membrane,oxygrnation), intermittent dialysis&#xD;
             or continuous dialysis during sampling&#xD;
&#xD;
          -  Patient hospitalized without consent and/or deprived of liberty by court decision.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toufik Kamel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHR Orléans, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thierry Boulain, MD</last_name>
    <phone>33238514444</phone>
    <email>thierry.boulain@chr-orleans.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aurélie Despujols</last_name>
    <phone>33238514444</phone>
    <email>aurelie.despujols@chr-orleans.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU d'ANGERS</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ACHILE KOUATCHET, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Achile KOUATCHET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de DIJON</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Pierre QUENOT, Pr</last_name>
    </contact>
    <investigator>
      <last_name>Jean Pierre QUENOT, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu de Garches</name>
      <address>
        <city>Garches</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NICHOLAS HEMING, Dr</last_name>
    </contact>
    <investigator>
      <last_name>NICHOLAS HEMING, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Limoges</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BRUNO EVRARD, Dr</last_name>
    </contact>
    <investigator>
      <last_name>BRUNO EVRARD, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de La Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JEREMY BOURENE, Dr</last_name>
    </contact>
    <investigator>
      <last_name>JEREMY BOURENE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de NANTES</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>KARIM LAKHAL, Dr</last_name>
    </contact>
    <investigator>
      <last_name>LAKHAL KARIM, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chr D'Orleans</name>
      <address>
        <city>Orléans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>TOUFIK KAMEL, Dr</last_name>
    </contact>
    <investigator>
      <last_name>TOUFIK KAMEL, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de POITIERS</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MAEVA RODRIGUEZ, Dr</last_name>
    </contact>
    <investigator>
      <last_name>MAEVA RODRIGUEZ</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de STRASBOURG</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>RALF JANSSEN-LANGENSTEIN, Dr</last_name>
    </contact>
    <investigator>
      <last_name>RALF JANSSEN-LANGENSTEIN, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch de Versailles</name>
      <address>
        <city>Versailles</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ALEXIS FERRE, Dr</last_name>
    </contact>
    <investigator>
      <last_name>ALEXIS FERRE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Boulain T, Garot D, Vignon P, Lascarrou JB, Benzekri-Lefevre D, Dequin PF; Clinical Research in Intensive Care and Sepsis (CRICS) Group. Predicting arterial blood gas and lactate from central venous blood analysis in critically ill patients: a multicentre, prospective, diagnostic accuracy study. Br J Anaesth. 2016 Sep;117(3):341-9. doi: 10.1093/bja/aew261.</citation>
    <PMID>27543529</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 29, 2020</study_first_submitted>
  <study_first_submitted_qc>August 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2020</study_first_posted>
  <last_update_submitted>June 14, 2021</last_update_submitted>
  <last_update_submitted_qc>June 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lactate</keyword>
  <keyword>arterial blood gas</keyword>
  <keyword>central venous blood</keyword>
  <keyword>gazometer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

